MLICM
DXC icon

Metropolitan Life Insurance Company (MetLife)’s DXC Technology DXC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DXC Stock Details DXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,488
Closed -$177K – 2358
2023
Q3 		$177K Sell
8,488
-1,433
-14% -$32.9K 0.01% 738
2023
Q2 		$265K Sell
9,921
-262
-3% -$6.52K 0.01% 577
2023
Q1 		$260K Sell
10,183
-3,121
-23% -$85.1K 0.01% 582
2022
Q4 		$353K Sell
13,304
-381
-3% -$10.6K 0.02% 537
2022
Q3 		$335K Sell
13,685
-1,039
-7% -$28.6K 0.02% 542
2022
Q2 		$446K Sell
14,724
-363
-2% -$11.3K 0.02% 515
2022
Q1 		$492K Sell
15,087
-13,717
-48% -$454K 0.02% 541
2021
Q4 		$927K Sell
28,804
-805
-3% -$26.2K 0.01% 1022
2021
Q3 		$995K Sell
29,609
-1,352
-4% -$51.2K 0.01% 951
2021
Q2 		$1.21M Sell
30,961
-460
-1% -$16.4K 0.02% 870
2021
Q1 		$982K Sell
31,421
-1,532
-5% -$42K 0.01% 936
2020
Q4 		$849K Sell
32,953
-1,729
-5% -$36.9K 0.01% 997
2020
Q3 		$619K Sell
34,682
-1,479
-4% -$27K 0.01% 1065
2020
Q2 		$597K Sell
36,161
-2,559
-7% -$40.7K 0.01% 1075
2020
Q1 		$505K Sell
38,720
-148
-0.4% -$3.91K 0.01% 1042
2019
Q4 		$1.46M Sell
38,868
-815
-2% -$26.6K 0.02% 707
2019
Q3 		$1.17M Sell
39,683
-824
-2% -$35.1K 0.02% 776
2019
Q2 		$2.23M Buy
40,507
+2,552
+7% +$148K 0.04% 472
2019
Q1 		$2.44M Sell
37,955
-2,762
-7% -$177K 0.04% 388
2018
Q4 		$2.16M Buy
40,717
+134
+0.3% +$9.26K 0.04% 381
2018
Q3 		$3.8M Sell
40,583
-2,105
-5% -$186K 0.06% 249
2018
Q2 		$3.44M Sell
42,688
-23,147
-35% -$1.99M 0.06% 276
2018
Q1 		$5.73M Buy
65,835
+297
+0.5% +$26K 0.08% 198
2017
Q4 		$5.38M Sell
65,538
-104,997
-62% -$8.48M 0.07% 206
2017
Q3 		$12.7M Sell
170,535
-1,759
-1% -$125K 0.08% 217
2017
Q2 		$11.4M Buy
+172,294
New +$11.4M 0.08% 234

Other funds holding DXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DXC Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of DXC Technology (DXC) in Q4 2023, closing a stake of 8,488 shares — an estimated $177K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DXC in Q2 2017 and held it in 26 quarters. The position peaked at $12.7M in Q3 2017. 434 funds tracked by Wall St. Rank hold DXC as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining DXC Technology position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,488 DXC Technology shares in Q4 2023, an estimated $177K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in DXC Technology in Q2 2017 and held it in 26 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s DXC Technology position peaked at $12.7M in Q3 2017.
  • 434 funds tracked by Wall St. Rank held DXC Technology as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.